Endothelial Cell Health Across the Spectrum of Cardiometabolic Disease
Project Number3R01HL168889-02S1
Former Number1R01HL168889-01
Contact PI/Project LeaderHAMBURG, NAOMI MIRIAM Other PIs
Awardee OrganizationBOSTON UNIVERSITY MEDICAL CAMPUS
Description
Abstract Text
Project Summary/Abstract
The escalating prevalence of cardiometabolic risk factors including obesity and type 2 diabetes mellitus
(T2DM) presents a critical cardiovascular challenge. Individuals with cardiometabolic disease harbor greater
risk of cardiovascular disease (CVD) including accelerated vascular aging and premature atherosclerotic
disease. Importantly, alterations in endothelial function predate the development of clinical CVD, making the
vascular endothelium an important potential target for cardioprotection. Experimental studies and our prior
work link altered metabolism to organelle stress including mitochondrial dysfunction and ER stress. In this
proposal, we hypothesize that organelle stress induced by cardiometabolic traits drives vascular dysfunction
and promotes CVD. We will leverage the unique resources of the planned Framingham Heart Study fourth
examination cycle to prospectively collect fresh human endothelial cells (EC) from 2000 individuals. In Aim 1,
we will investigate the association of T2DM and cardiometabolic traits with EC phenotype including organelle
stress and nitric oxide signaling in a nested case-control sample of 450 individuals. In Aim 2, we will measure
EC gene expression levels using RNA sequencing in 900 participants to identify and prioritize EC
transcriptional programs linked to EC health phenotypes, cardiometabolic traits, and systemic metabolism. This
proposal leverages a unique and highly experienced multidisciplinary team of investigators with expertise in
obesity-related cardiovascular disease, endothelial biology, population science, translational patient-oriented
research, multi-omics and bioinformatics. The proposed work will dwarf past efforts at defining endothelial
health across disease states and will combine new deep phenotyping of EC conducted at scale in a
community-based cohort with existing rigorous measures of cardiovascular health including metabolite profiles
and genomic markers. These studies have the potential to provide important insights into mechanisms driving
endothelial dysfunction and develop an unprecedented resource that will benefit vascular biology research.
Public Health Relevance Statement
Project Narrative (Public Health Relevance)
Given the rising burden of obesity, diabetes, and heart disease in the community, new approaches are needed
to maintain blood vessel health from the impact of cardiometabolic traits. The proposed research investigates
the impact of cardiometabolic diseases on health of the blood vessel lining cells, endothelial cells, by
measuring stress markers and gene expression pathways. Our results will clarify how cardiometabolic
diseases result in different patterns of endothelial cell gene expression and may identify novel molecular
underpinnings of cardiovascular risk that will have important preventive and therapeutic implications.
No Sub Projects information available for 3R01HL168889-02S1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 3R01HL168889-02S1
Patents
No Patents information available for 3R01HL168889-02S1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 3R01HL168889-02S1
Clinical Studies
No Clinical Studies information available for 3R01HL168889-02S1
News and More
Related News Releases
No news release information available for 3R01HL168889-02S1
History
No Historical information available for 3R01HL168889-02S1
Similar Projects
No Similar Projects information available for 3R01HL168889-02S1